Binds HER2 on tumor cells and engages FcγR-bearing immune effectors to mediate ADCC (NK cells) and ADCP (macrophages), leading to killing of HER2-expressing cells; also blocks HER2 signaling but cytotoxicity is via Fc-mediated effector functions.